Health Gorilla Calls Epic Lawsuit ‘Attack on Interoperability’ in Motion to Dismiss
Katie Adams / medcitynews - Health data company Health Gorilla filed a motion to dismiss a lawsuit from Epic and several healthcare providers alleging inappropriate access to nearly 300,000 patient records. The case highlights ongoing questions about governance and standards for nat…
AI Summary: Health Gorilla has asked a court to toss Epic’s lawsuit accusing the health‑data firm of improper access to electronic health records, calling the suit an “attack on interoperability.” The motion argues Epic and providers are using contract technicalities to stifle data exchange, while courts will decide whether access practices cross legal lines.
Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model
fiercehealthcare - Teladoc Health reported better-than-expected fourth quarter financial results with both revenue and earnings exceeding analysts' expectations, driving a 15% jump in the company's stock Thursday.
AI Summary: Telehealth provider Teladoc reported slower growth and issued a cautious outlook as it shifts its telehealth model, warning of membership headwinds and potential declines in integrated‑care enrollment tied to market dynamics and policy changes. Management signaled strategic recalibration to stabilize long‑term performance.
CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
fiercehealthcare - Elevance Health Chief Financial Officer Mark Kaye will grow his list of duties to include oversight of Carelon, the company announced Thursday.
AI Summary: Elevance Health elevated CFO Mark Kaye to take expanded responsibility overseeing Carelon as part of a broader C-suite reshuffle. The reorganization centralizes oversight of the company’s growth arm and signals a tighter alignment between payer operations and its care-management business amid strategic and operational realignments.
Generate Biomedicines’ $400M IPO Puts AI Drug Discovery Back in Focus
oncodaily - Generate Biomedicines priced its U.S. initial public offering on February 26, 2026, selling 25 million shares at $16 each for gross proceeds of $400 million, with trading expected on the Nasdaq under […]
AI Summary: Generate Biomedicines priced a U.S. IPO at $16 per share, selling 25 million shares and raising about $400 million to advance AI-designed drugs — notably a less-frequent injection candidate for severe asthma. The offering renews investor appetite for AI-driven biotech and funds pivotal clinical work, while whispering about a lofty post-listing valuation.
ChatGPT Health performance in a structured test of triage recommendations
Ashwin Ramaswamy / nature - Nature Medicine, Published online: 23 February 2026; doi:10.1038/s41591-026-04297-7A stress test of ChatGPT Health triage revealed missed high-risk emergencies and inconsistent activation of suicide-crisis safeguards, raising safety concerns for consumer-…
AI Summary: A structured, independent evaluation found that ChatGPT Health—an AI tool offering consumer triage and health guidance—missed or misclassified high-risk cases and gave inconsistent advice. Researchers and clinicians raised safety concerns about relying on the system for urgent medical decision-making, calling for tighter oversight and validation before broad public deployment.
‘You’re not the Lone Ranger’ anymore: Medical education evolves for team-based care
Paige Twenter / beckershospitalreview - As U.S. healthcare increasingly adopts team-based care, medical schools are working to prepare students for future care delivery models, according to a Feb. 18 article from the Association of American Medical Colleges. Team-based care, or a coordinated ba…
AI Summary: A multi‑agent AI system called DeepRare has proven it can outpace physicians in head‑to‑head rare‑disease diagnosis tests, promising to shorten the notorious “diagnostic odyssey.” Industry leaders tout this as a practical diagnostic aid, while experts caution about validation, integration into clinical workflows and equity in access before it replaces any human judgment.
Optum unveils Value Connect, its AI-powered tool to support value-based care
fiercehealthcare - Optum is rolling out a new AI tool that aims to address some of the key barriers to value-based care, from data fragmentation to administrative burden.
AI Summary: Optum launched Value Connect, an AI-driven platform aimed at unifying fragmented payer and provider data to operationalize value-based care. The tool promises integrated data analytics, risk stratification, and workflow automation to reduce administrative friction and help health systems meet value contracts—essentially a tech fix for healthcare’s chronically leaky data plumbing.
Hims to buy Australia’s Eucalyptus for $240M upfront in global push
Ngai Yeung / endpoints - In a bid to build out its global presence, Hims is buying Australian digital health company Eucalyptus in a deal worth $240 million upfront. The deal announced Thursday morning would allow Hims to launch in ...
AI Summary: Hims & Hers is moving aggressively into international telehealth by acquiring Australia’s Eucalyptus, a deal various reports value in the low‑to‑mid hundreds of millions to over a billion depending on earnouts. The purchase gives the U.S. digital health company an immediate footprint in Australia, Japan and other markets as it chases global scale.
Mississippi hospital system closes all clinics after ransomware attack
abcnews - A ransomware attack has forced the University of Mississippi Medical Center to close clinics and cancel elective procedures for a second day
AI Summary: A cyberattack forced the University of Mississippi Medical Center to take Epic and other systems offline, leading to canceled appointments, closed clinics and an FBI response. Officials say investigations are ongoing while clinicians scramble to deliver care without their usual electronic lifelines.
Can medical AI lie? Large study maps how LLMs handle health misinformation
medicalxpress - Medical artificial intelligence (AI) is often described as a way to make patient care safer by helping clinicians manage information. A new study by the Icahn School of Medicine at Mount Sinai and collaborators confronts a critical vulnerability: when a m…
AI Summary: A broad analysis — including Mount Sinai research — shows large language models and medical AI systems can propagate false or misleading health claims when presented in realistic clinical language. Findings expose safety gaps, underline risks of unchecked deployment, and call for tighter guardrails, validation and clinician oversight before clinical use.
Physicians push back on Alabama robotic ultrasound proposal
Mariah Taylor / beckershospitalreview - Alabama’s proposal to use robotic ultrasounds to close care gaps is being praised by national leaders but facing pushback from local physicians, KFF Health News reported Feb. 12. Alabama is facing above national average rates for infant mortality on top o…
AI Summary: Alabama’s plan to expand robotics in maternity services — including proposals for robotic ultrasounds and other automation — has provoked physician backlash. Clinicians warn that substituting machines for bedside assessment could erode accountability and patient safety in a state already wrestling with poor maternal outcomes, triggering a heated debate about technology versus hands‑on care.
Lilly appeals retatrutide classification ruling in case that could impact compounders
Alexis Kramer / endpoints - Eli Lilly is challenging a decision over how the FDA classified its experimental, next-gen obesity shot, in a case that could affect the ability of compounders to rival it. On Thursday, Lilly filed a notice ...
AI Summary: Eli Lilly is contesting a regulatory classification decision for its next‑generation obesity shot while simultaneously stockpiling doses ahead of potential U.S. approval. The dispute has broader implications for compounding pharmacies and has coincided with lawsuits accusing telehealth vendors and compounders of selling unapproved oral GLP‑1 alternatives — a messy intersection of commerce, regulation and patient safety.
New FDA-Approved Device Uses Electric Fields to Treat Pancreatic Cancer
discovermagazine - Learn more about the newly approved wearable treatment that disrupts pancreatic cancer tumor growth while letting patients continue daily life at home.
AI Summary: The FDA approved a wearable device that delivers alternating electric fields to disrupt pancreatic tumor growth, letting patients remain ambulatory while receiving treatment. Clinicians hail the noninvasive approach as a new adjunct to standard care, aiming to slow progression in a cancer that’s notoriously hard to treat — and yes, it literally plugs into hope.
Solace Health Reaches Unicorn Status by Taking the ‘Homework’ Out of Care Navigation
Katie Adams / medcitynews - Health advocate network Solace Health gained unicorn status after closing a $130 million Series C funding round. The startup’s advocates help with tasks like scheduling appointments, finding in-network providers, understanding insurance coverage and bills…
AI Summary: Care navigation startup Solace Health closed a $130 million Series C, achieving a $1 billion valuation by expanding its patient advocacy network that helps members navigate benefits and care. The funding will scale operations and deepen employer and payer partnerships aimed at reducing administrative friction.
Talkiatry Rakes In $210M to Scale Virtual Psychiatry Group
Katie Adams / medcitynews - Telepsychiatry provider Talkiatry has raised a $210 million Series D round led by Perceptive Advisors, bringing its total funding to more than $400 million. CEO Robert Krayn said the company is focused on scaling its clinician-employed model and improving…
AI Summary: Talkiatry closed a $210 million Series D led by Perceptive Advisors to scale its virtual psychiatry platform, expanding telepsychiatry access and accelerating growth plans. The financing positions the company to beef up operations, hire talent, and deepen partnerships as demand for remote mental health care surges.
500M records exchanged through TEFCA, federal health IT office boasts
fiercehealthcare - At the 2026 Annual Meeting for the health IT office at HHS, officials announced a massive spike in the number of health records shared through the government-backed TEFCA initiative. The number seems to reflect the heavy focus Trump's HHS has put on digit…
AI Summary: The federal Trusted Exchange Framework and Common Agreement (TEFCA) has passed roughly 500 million health records exchanged across participating networks, a milestone officials say will accelerate interoperability and data flow. The milestone spotlights rapid uptake and complementary data initiatives—plus the governance and privacy work that now comes with scale.
AI model reads brain MRIs in seconds, hitting up to 97.5% accuracy
medicalxpress - An AI-powered model developed at the University of Michigan can read a brain MRI and diagnose a person in seconds, a study suggests. The model detected neurological conditions with up to 97.5% accuracy and predicted how urgently a patient required treatme…
AI Summary: Researchers at the University of Michigan have unveiled an AI-powered model that reads brain MRIs in seconds with up to 97.5% accuracy. This breakthrough promises to ease radiologist workloads and dramatically speed up neurodiagnostics, potentially transforming clinical workflows in imaging.
Epic rolls out AI Charting tool
Naomi Diaz / beckershospitalreview - Epic has rolled out AI Charting, a built-in tool that listens during patient visits and drafts clinicians’ notes and suggested orders in real time. The feature is part of Epic’s expanding set of AI capabilities built directly into its software, according …
AI Summary: Epic has launched an integrated AI–powered charting tool designed to automate note–taking and suggest orders during patient visits, a strategic move aimed at reducing documentation burden and streamlining clinical workflow in a competitive ambient scribe market.
Novo Nordisk vows legal action to protect Wegovy pill
medicalxpress - Novo Nordisk said Thursday it would take legal action against a US chain offering a copycat of the new pill version of its Wegovy weight-loss drug.
AI Summary: Novo Nordisk has vowed to take legal action after discovering that competitors – including Hims & Hers – plan to market a compounded, lower‐priced version of its new Wegovy weight‐loss pill. The company is mobilizing its legal team to protect its intellectual property amid fierce market competition.
Meditech founder and EHR innovator A. Neil Pappalardo dies at 83
fiercehealthcare - Pappalardo is considered a tech pioneer with a 56-year career that started when he founded electronic health record company Meditech in 1969, a company he steered to become one of the leading EHR companies.
AI Summary: Tech pioneer A. Neil Pappalardo – the founder of Meditech whose 56‐year career revolutionized electronic health records – has passed away at 83. His contributions reshaped healthcare IT and continue to influence clinical practice worldwide.